Commission Decision of 19 March 2002 laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council (notified under document number C(2002) 1043) (2002/253/EC) (repealed)

[F1RUBELLA (Rubella virus) U.K.

Clinical criteria U.K.

Any person with sudden onset of generalised maculo-papular rash

AND

At least one of the following five:

  • Cervical adenopathy

  • Sub-occipital adenopathy

  • Post-auricular adenopathy

  • Arthralgia

  • Arthritis

Laboratory criteria U.K.

  • Laboratory criteria for case confirmation

    At least one of the following three:

  • Isolation of rubella virus from a clinical specimen

  • Detection of rubella virus nucleic acid in a clinical specimen

  • Rubella virus specific antibody response (IgG) in serum or saliva

  • Laboratory criteria for probable case

  • Rubella virus specific antibody response (IgM) (1)

Laboratory results need to be interpreted according to the vaccination status

Epidemiological criteria U.K.

An epidemiological link by human to human transmission

Case classification U.K.

A. Possible case U.K.

Any person meeting the clinical criteria

B. Probable case U.K.

Any person meeting the clinical criteria and with at least one of the following two:

  • An epidemiological link

  • Meeting the laboratory criteria for a probable case

C. Confirmed case U.K.

Any person not recently vaccinated and meeting the laboratory criteria for case confirmation

In case of recent vaccination, a person with detection of wild-type rubella virus strain]

Textual Amendments

(1)

[F1When rubella in pregnancy is suspected, further confirmation of a positive rubella IgM results is required (e.g. a rubella specific IgG avidity test showing a low avidity). In certain situations, such as confirmed rubella outbreaks detection of rubella virus IgM can be considered confirmatory in non-pregnant cases.]

Textual Amendments